Personal tools

MCL coexpression mm9:1454: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002346!2.69e-27!64;UBERON:0003075!2.69e-27!64;UBERON:0007284!2.69e-27!64;UBERON:0004121!6.14e-27!95;UBERON:0000924!6.14e-27!95;UBERON:0006601!6.14e-27!95;UBERON:0001017!4.32e-26!73;UBERON:0010371!3.21e-25!73;UBERON:0001016!7.88e-25!75;UBERON:0000073!1.14e-21!54;UBERON:0003056!1.19e-21!49;UBERON:0010314!2.27e-21!92;UBERON:0001049!1.20e-20!52;UBERON:0005068!1.20e-20!52;UBERON:0006241!1.20e-20!52;UBERON:0007135!1.20e-20!52;UBERON:0000955!7.76e-18!47;UBERON:0006238!7.76e-18!47;UBERON:0002616!3.76e-17!46;UBERON:0003080!5.60e-16!40;UBERON:0002780!2.50e-15!39;UBERON:0001890!2.50e-15!39;UBERON:0006240!2.50e-15!39;UBERON:0002020!3.49e-14!34;UBERON:0003528!1.62e-11!29;UBERON:0002791!1.62e-11!29;UBERON:0001893!1.62e-11!29;UBERON:0000468!4.85e-09!333;UBERON:0000956!2.97e-07!21;UBERON:0001869!2.97e-07!21;UBERON:0000203!2.97e-07!21;UBERON:0000922!5.55e-07!320;UBERON:0000020!7.40e-07!12;UBERON:0001032!7.40e-07!12;UBERON:0004456!7.40e-07!12
|ontology_enrichment_uberon=UBERON:0002346!2.69e-27!64;UBERON:0003075!2.69e-27!64;UBERON:0007284!2.69e-27!64;UBERON:0004121!6.14e-27!95;UBERON:0000924!6.14e-27!95;UBERON:0006601!6.14e-27!95;UBERON:0001017!4.32e-26!73;UBERON:0010371!3.21e-25!73;UBERON:0001016!7.88e-25!75;UBERON:0000073!1.14e-21!54;UBERON:0003056!1.19e-21!49;UBERON:0010314!2.27e-21!92;UBERON:0001049!1.20e-20!52;UBERON:0005068!1.20e-20!52;UBERON:0006241!1.20e-20!52;UBERON:0007135!1.20e-20!52;UBERON:0000955!7.76e-18!47;UBERON:0006238!7.76e-18!47;UBERON:0002616!3.76e-17!46;UBERON:0003080!5.60e-16!40;UBERON:0002780!2.50e-15!39;UBERON:0001890!2.50e-15!39;UBERON:0006240!2.50e-15!39;UBERON:0002020!3.49e-14!34;UBERON:0003528!1.62e-11!29;UBERON:0002791!1.62e-11!29;UBERON:0001893!1.62e-11!29;UBERON:0000468!4.85e-09!333;UBERON:0000956!2.97e-07!21;UBERON:0001869!2.97e-07!21;UBERON:0000203!2.97e-07!21;UBERON:0000922!5.55e-07!320;UBERON:0000020!7.40e-07!12;UBERON:0001032!7.40e-07!12;UBERON:0004456!7.40e-07!12
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.473747,0.464605,0.535892,0.346849,0.550971,0.645383,0.691572,0.257202,0.283981,0.599767,0.632897,1.28144,0.6581,0.955327,0,0.856992,0.338549,0.656199,0.86893,0.426133,0.35122,0.657163,0.345236,0.472505,1.64218,0.223823,1.40396,0.394364,0.181062,0.558142,0.960397,1.60284,0.204204,0.364821,0.607065,0.326478,0.629145,0.303703,1.37841,0.342638,0.56353,0.327433,0.366415,0.368882,0.524258,0.77511,0.589246,0.284064,0.397446,0.839084,0.714419,0.517905,1.10437,1.12205,0.66551,1.04848,0.619643,0.21472,0.663395,0.939962,0.724164,0.742129,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.253541,0.740068,1.156,0.208101,0.57254,0.589776,0.763395,0.922432,0.430551,0.254777,0.874787,0.722675,0.240896,1.03903,0.198949,0.0610418,0.181203,0.780154,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.281222,0.685716,0.976308,0.775372,0.483322,0.326561,0.960112,1.08669,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,1.21641,1.0885,0.431734,0.605144,1.33732,0.340765,0.0704207,1.33416,0.858327,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.356163,1.06946,0.52828,1.2285,0.679647,1.35909,0.106956,0.500709,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.920761,0.540361,0.325363,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,0.48935,0.500417,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,0.325308,0.63125,0.0323861
}}
}}

Revision as of 19:56, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr3:126928812..126928833,-p11@Ank2
Mm9::chr3:126928835..126928877,-p2@Ank2
Mm9::chr3:133902218..133902243,+p@chr3:133902218..133902243
+
Mm9::chr6:93862948..93862971,-p@chr6:93862948..93862971
-
Mm9::chr8:42140224..42140231,-p22@Mtus1
Mm9::chr9:122812220..122812280,-p1@ENSMUST00000155444


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
neuron3.81e-1533
neuronal stem cell3.81e-1533
neuroblast3.81e-1533
electrically signaling cell3.81e-1533
CNS neuron (sensu Vertebrata)1.20e-1223
neuroblast (sensu Vertebrata)1.20e-1223
ectodermal cell4.11e-1044
neurectodermal cell4.11e-1044
neural cell1.15e-0943
electrically responsive cell1.19e-0939
electrically active cell1.19e-0939

Uber Anatomy
Ontology termp-valuen
neurectoderm2.69e-2764
neural plate2.69e-2764
presumptive neural plate2.69e-2764
ectoderm-derived structure6.14e-2795
ectoderm6.14e-2795
presumptive ectoderm6.14e-2795
central nervous system4.32e-2673
ecto-epithelium3.21e-2573
nervous system7.88e-2575
regional part of nervous system1.14e-2154
pre-chordal neural plate1.19e-2149
structure with developmental contribution from neural crest2.27e-2192
neural tube1.20e-2052
neural rod1.20e-2052
future spinal cord1.20e-2052
neural keel1.20e-2052
brain7.76e-1847
future brain7.76e-1847
regional part of brain3.76e-1746
anterior neural tube5.60e-1640
regional part of forebrain2.50e-1539
forebrain2.50e-1539
future forebrain2.50e-1539
gray matter3.49e-1434
brain grey matter1.62e-1129
regional part of telencephalon1.62e-1129
telencephalon1.62e-1129
multi-cellular organism4.85e-09333
cerebral cortex2.97e-0721
cerebral hemisphere2.97e-0721
pallium2.97e-0721
embryo5.55e-07320
sense organ7.40e-0712
sensory system7.40e-0712
entire sense organ system7.40e-0712


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}